The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31

Mostrar otras versiones (1)

Amplification of the EMSY gene in sporadic breast and ovarian cancers is a poor prognostic indicator. Although EMSY has been linked to transcriptional silencing, its mechanism of action is unknown. Here, we report that EMSY acts as an oncogene, causing the transformation of cells in vitro and potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Viré, Emmanuelle, Curtis, Christina, Davalos, Veronica, Git, Anna, Robson, Samuel, Villanueva, Alberto, Vidal, August, Barbieri, Isaia, Aparicio, Samuel, Esteller, Manel, Caldas, Carlos, Kouzarides, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988886/
https://www.ncbi.nlm.nih.gov/pubmed/24582497
http://dx.doi.org/10.1016/j.molcel.2014.01.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988886/
https://www.ncbi.nlm.nih.gov/pubmed/24582497
http://dx.doi.org/10.1016/j.molcel.2014.01.029

Ejemplares similares